QT
ATRC icon

Quantamental Technologies’s AtriCure ATRC Stock Holding History

Quantamental Technologies’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,748
Closed -$93K – 490
2019
Q3 		$93K Buy
3,748
+3,079
+460% +$87.9K 0.03% 764
2019
Q2 		$20K Sell
669
-2,380
-78% -$69.5K 0.01% 1126
2019
Q1 		$82K Buy
+3,049
New +$92.6K 0.04% 671

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Quantamental Technologies's ATRC Position: Q4 2019 in Review

Quantamental Technologies sold out of AtriCure (ATRC) in Q4 2019, closing a stake of 3,748 shares — an estimated $93K sold.

Quantamental Technologies first reported a position in ATRC in Q1 2019 and held it in 3 quarters. The position peaked at $93K in Q3 2019. 141 funds tracked by Wall St. Rank hold ATRC as of Q4 2019.

  • Quantamental Technologies reported no remaining AtriCure position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 3,748 AtriCure shares in Q4 2019, an estimated $93K.
  • Quantamental Technologies first reported a position in AtriCure in Q1 2019 and held it in 3 quarters.
  • Quantamental Technologies's AtriCure position peaked at $93K in Q3 2019.
  • 141 funds tracked by Wall St. Rank held AtriCure as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.